{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Giordano L"],"funding":["Associazione Italiana per la Ricerca sul Cancro"],"pagination":["785"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5700540"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["17(1)"],"pubmed_abstract":["<h4>Background</h4>In recent years growing interest has been posed on alternative ways to screen women for breast cancer involving different imaging techniques or adjusting screening interval by breast cancer risk estimates. A new research area is studying circulating microRNAs as molecular biomarkers potentially useful for non invasive early detection together with the analysis of single-nucleotide polymorphisms (SNPs). The Andromeda study is a prospective cohort study on women attending breast cancer screening in a northern Italian area. The aims of the study are: 1) to define appropriate women risk-based stratifications for personalized screening considering different factors (reproductive, family and biopsy history, breast density, lifestyle habits); 2) to evaluate the diagnostic accur"],"journal":["BMC cancer"],"pubmed_title":["The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol."],"pmcid":["PMC5700540"],"funding_grant_id":["IG 2014 Id 15374"],"pubmed_authors":["Favettini E","Ostano P","Feira S","Giordano L","Debianchi A","Vergini V","Ayoubi SH","Casella D","Pitarella S","Giubilato P","Vicari P","Menardi A","Andromeda working group","Anatrone C","Gallo F","Artuso F","Segnan N","Ceresa M","Dotti M","Frigerio A","Marra V","Ponti A","Mello-Grand M","Mano MP","Petracci E","Pezzana A","Gregnanin I","Chiorino G","Beraudi M","Ortale A","Saba F","Pelosin S","Di Stefano F","Iacazio L","Garena F","Presti P"],"additional_accession":[]},"is_claimable":false,"name":"The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.","description":"<h4>Background</h4>In recent years growing interest has been posed on alternative ways to screen women for breast cancer involving different imaging techniques or adjusting screening interval by breast cancer risk estimates. A new research area is studying circulating microRNAs as molecular biomarkers potentially useful for non invasive early detection together with the analysis of single-nucleotide polymorphisms (SNPs). The Andromeda study is a prospective cohort study on women attending breast cancer screening in a northern Italian area. The aims of the study are: 1) to define appropriate women risk-based stratifications for personalized screening considering different factors (reproductive, family and biopsy history, breast density, lifestyle habits); 2) to evaluate the diagnostic accur","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Nov","modification":"2026-04-30T14:27:03.851Z","creation":"2019-03-27T03:02:47Z"},"accession":"S-EPMC5700540","cross_references":{"pubmed":["29166878"],"doi":["10.1186/s12885-017-3784-5"]}}